Business Wire

BearingPoint and ABeam Consulting announce strategic joint venture in the United States to deliver seamless global business transformation

2.9.2025 12:15:00 EEST | Business Wire | Press release

Share

BearingPoint and ABeam Consulting are proud to announce the formation of a new joint venture in the United States, marking a significant milestone in their long-standing strategic alliance. The new entity will operate under the BearingPoint brand and be legally registered as BearingPoint NA LLC. Headquartered in Chicago, its mission is to deliver end-to-end SAP consulting and implementation including SAP Business AI services for clients across the Americas, with a particular focus on the US market and complementing both parties’ global SAP capabilities.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250901891270/en/

BearingPoint and ABeam Consulting are proud to announce the formation of a new joint venture in the United States, marking a significant milestone in their long-standing strategic alliance.

This joint venture builds on the enhanced alliance structure announced in July 2025, which expanded BearingPoint and ABeam Consulting’s ability to deliver seamless global business transformation services across Europe, Asia, and the Americas. It combines the strengths of two globally recognized consulting firms to launch the vanguard of SAP powered digital transformation. With a shared investment structure and a joint leadership model from BearingPoint and ABeam Consulting, the new entity is designed to deliver scalable, high-impact SAP focused transformation programs with local relevance and global reach.

Strategic focus and market impact

The joint venture will serve American, European, and Japanese clients, with a particular emphasis on the Automotive & Industrial, Chemicals, Life Sciences & Resources, and Consumer Goods & Retail sectors. The venture will offer a full scope of SAP services – from business consulting and technical implementation to managed services and IP-based product offerings. By aiming to become the SAP partner of choice for upper mid-sized and large clients in the U.S., the new entity leverages both parent firms’ deep industry expertise, delivery capabilities, and proven transformation assets and products.

As an SAP Gold Partner and multi-award winner – including recognition through SAP Pinnacle Awards – BearingPoint, together with ABeam, brings decades of experience and a combined pedigree in delivering more than 1,500 SAP projects across 78 countries. This expertise complements ABeam’s strong SAP footprint in Asia and supports the joint venture’s ambition to deliver outcome-driven transformation at scale. In addition, the two partners bring together 15,000 professionals so that clients benefit from an end-to-end transformation capability across the globe.

The initiative reflects both firms’ commitment to helping clients navigate complexity with precision and purpose. Central to this approach lies a shared methodology: Strategic Navigation – combining human insight, industry expertise, and intelligent use of technology to guide clients through uncertainty and deliver transformation that lasts. It also aligns with BearingPoint’s broader ambition to scale globally and deliver technology-enabled consulting through its Strategy 2030 framework.

Executive Perspectives

Matthias Loebich, Managing Partner, BearingPoint, comments:

“This joint venture marks the next chapter in a global partnership built on trust, shared values, and a long-term commitment to client success. Together with ABeam, we are creating a truly collaborative platform for SAP driven digital transformation: one that combines our regional strengths, cultural alignment, and proven delivery capabilities. It will not only allow us to scale our consulting presence in the U.S., but it will also enable us to deliver high-value services to our clients across the globe. In a market that rewards clarity, specialization, and trust, our Strategic Navigation methodology guides organizations from strategic intent to measurable outcomes while keeping transformations on course.

As we expand our footprint in the U.S., we are also advancing our Strategy 2030 – uniting a people-first mindset with industry expertise and technology leadership to help clients achieve lasting business impact – worldwide.”

Takahiro Yamada, President and CEO, ABeam Consulting, comments:

“This joint venture is more than a business initiative; it is the natural evolution of a strong and long-term partnership. Together with BearingPoint, we are launching a new force in digital transformation and SAP consulting – one that combines deep manufacturing expertise, agile delivery, and local insight to meet the evolving needs of our clients in the U.S.

At the same time, we are establishing an unparalleled consulting structure to support global companies seeking growth in the Americas – a region with strong expectations for continued economic expansion and one of the most important markets for Japanese and other Asian businesses. We are also actively incorporating innovation from the U.S., where diverse advanced technologies are emerging, to further enhance the value of our SAP consulting services. This includes cutting-edge solutions such as generative AI, supporting companies in becoming AI-native by integrating AI into business management and customer value creation, and promoting sustainable transformation and new value creation. We remain committed to contributing as a real partner – creating economic and social value through the transformation of our clients.”

About ABeam Consulting
ABeam Consulting is an integrated management consulting firm that provides global services tailored to each country and region through its worldwide network centered in Asia. The wide range of consulting services it provides include strategy, BPR, IT, organization/personnel, outsourcing and other domains of specialized expertise. Roughly 8,800 richly experienced professional ABeam consultants advise in the areas of finance, manufacturing, distribution, energy, information communications, as well as industry, and organizations in the public sector and other sectors. ABeam Consulting creates the future together with corporations and other organizations. As a creative partner leading the way reliably through change, we contribute to industrial and societal change.

About BearingPoint
BearingPoint is an independent management and technology consultancy with European roots and a global reach that transforms businesses using technology intelligently. The firm operates across three core units: Consulting, Products, and Capital. Its Consulting services focus on selected areas, combining business and technology expertise with profound industry knowledge. The Products unit provides IP-driven solutions and managed services for business-critical processes. Capital delivers deal advisory and transaction services. In addition to its core operations, BearingPoint runs two joint ventures: Arcwide, a JV with IFS, which specializes in business transformation based on IFS technology, and BearingPoint North America, a JV with ABeam, which is dedicated to consulting excellence and business transformation built on SAP.

BearingPoint serves many of the world’s leading companies and organizations. Together with its strategic alliance partner ABeam Consulting, the firm brings together 15,000 professionals and supports clients in over 70 countries, delivering seamless business transformation with sustainable impact.

BearingPoint is a certified B Corporation, driven by a strong sense of purpose – today and into the future.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250901891270/en/

Contacts

For more information, please visit:
BearingPoint
Homepage: www.bearingpoint.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.bearingpoi
nt.com%2F&esheet=54316316&newsitemid=20250901891270&lan=en-US&anchor=www.bearing
point.com&index=1&md5=33f1828cef295f0e4338b47a9aaea6ab
LinkedIn: www.linkedin.com/company/bearingpoint -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.linkedin.co
m%2Fcompany%2Fbearingpoint&esheet=54316316&newsitemid=20250901891270&lan=en-US&a
nchor=www.linkedin.com%2Fcompany%2Fbearingpoint&index=2&md5=a80a40d7e04056447b8b
98521198022d

ABeam
Homepage: www.abeam.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.abeam.com&e
sheet=54316316&newsitemid=20250901891270&lan=en-US&anchor=www.abeam.com&index=3&
md5=ada17f0c7c5c407ca8d1fe012bfcc981

Press contacts
Molly Keating
US Head Marketing & Communications
Telephone: +1 872 877 3044
Email: molly.keating@bearingpoint.com

Mike Kronfellner
Global Head Marketing & Communications
Telephone: +49 89 54033 7070
Email: mike.kronfellner@bearingpoint.com

Wakana Kabasawa
Director Corporate Communications
Telephone: +81 80 2003 1833
Email: wkabasawa@abeam.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye